UNFPA Armenia Presented the “Prevalence and Reasons of Sex Selective Abortions in Armenia” Report
By Public Radio of Armenia,
Public Radio of Armenia
| 12. 19. 2011
Prof. Razmik Abrahamyan, Director of Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology, and Mr. Garik Hayrapetyan, UNFPA Armenia Assistant Representative presented the “Prevalence and Reasons of Sex Selective Abortions in Armenia” Report today.
As the speakers noted, the report contained both positive and alarming findings. In particular, the majority of the surveyed women have started having children in a favorable reproductive age: from 19 to 35 years old, which is very important in terms of safe motherhood. Another extremely positive finding is that the Armenian society provides the same care to already born children irrespective of their sex.
However, as to the future children, the society prefers boys much more than girls – around six times. The study suggests that 0.8 per cent of 900,000 Armenian women of reproductive age have had a sex selective abortion in the last five years. This means that each year Armenia potentially loses around 1400 future mothers.
According to the speakers, the report is based on the findings of a quantitative survey of 2830 households in the period of July 15-August 15, 2011...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Jay S. Kaufman, Los Angeles Review of Books | 09.27.2025
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...